Drugs in Health and Disease 2 (Prescribing in children) Flashcards
How is the size of the paediatric matter affect prescribing?
Give an example of this
- Range from 0.5-90kg
- Paediatric prescribing is by weight- with adult ceiling
- Some drugs by surface area
Furosemide 40mg daily in adult, 1mg/kg daily
Growth hormone
There is scope or confusions with administering small doses
How should these be written?
Write in full
- micrograms, nanograms
Don’t use unnecessary decimal points
- 3mg as opposed to 3.0mg
- 100 micrograms, not 0.1mg
Describe the altered kinetics in neonates
Immature liver enzymes
- opiates are cleared slowly
- “short acting” benzodiazepines metabolised slower
Low GFR at birth
- give lower dose at wider intervals for aminoglycosides
Dosage schedules change after first few weeks
For the following drugs, what adverse effects are more pronounced in children
- Benzodiazepines/opiates
- Chloramphenical
- Aspirin
- Phenobarbitone vs amphetamines
- Apnoea in infants, immature liver + resp control
- “grey baby” reaction in neonates, liver immaturity
- Reyes syndrome
- Paradoxical psychotropic effects
What considerations should you make in terms of delivery of medications to children?
Avoid unnecessary pain:
- IM injections rarely used,
- Long term venous access devices used if repeated IV infusions needed
Liquid preparations (if available)
- young children have difficulties swallowing tablets
- tablet doses are inflexible
- problems for slow release formulations
How would you give inhaled medications
- Metered dose inhaler requires complex coordination
- at school age; dry powder inhaler
- preschool age: MDI+ spacer +/- mask
- always specify the delivery device
What are the licensing issues surrounding paediatric use
- many drugs dont have paediatric licensing (difficulties in drug trials)
- “off licence” prescribing: where there is no licence, or child is below licensed age, its legal but the prescriber takes responsibility,
Consider the drugs affect the ductus arteriosus (passage between pumonary artery and aorta)
What drugs are used to close a patent ductus arteriosus?
Indomethacin/Ibuprofen
- COX1 inhibitors which prevent prostaglandin synthesis
- IV/oral (no liquid prep)
- Variable availability
- side effects: renal failure (due to decreased GFR), bleeding (due to decreased platelet function), necrotising enterocolitis (decreased gut blood flow)
Consider the drugs affect the ductus arteriosus (passage between pulmonary artery and aorta)
What drugs are used to keep a patent ductus arteriosus?
Prostaglandin E1 or E2
- IV infusion 10nanog/kg/minute;
- Oral 20microg/kg 2hourly
- Problems: apnoea